These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 3048633

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Active specific immunotherapy and immunochemotherapy in the treatment of lung and colon cancer.
    Hollinshead A.
    Semin Surg Oncol; 1991; 7(4):199-210. PubMed ID: 1925251
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adjuvant, specific, active immunotherapy for resectable squamous cell lung carcinoma: a 5-year survival analysis.
    Takita H, Hollinshead AC, Adler RH, Bhayana J, Ramundo M, Moskowitz R, Rao UN, Raman S.
    J Surg Oncol; 1991 Jan; 46(1):9-14. PubMed ID: 1986150
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adjuvant specific immunotherapy of resectable squamous cell lung carcinoma. Analysis at the eighth year.
    Takita H, Hollinshead A, Hart T, Bhayana J, Adler R, Rao U, Moskowitz R, Ramundo M.
    Cancer Immunol Immunother; 1985 Jan; 20(3):231-5. PubMed ID: 3904977
    [Abstract] [Full Text] [Related]

  • 10. Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method.
    Nakatsura T, Senju S, Ito M, Nishimura Y, Itoh K.
    Eur J Immunol; 2002 Mar; 32(3):826-36. PubMed ID: 11870627
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Role of immunotherapy in the combined treatment of lung cancer].
    Trapeznikov NN, Gorodilova VV, Babakova SV, Kadagidze ZG, Trakhtenberg AKh.
    Vopr Onkol; 1982 Mar; 28(2):51-6. PubMed ID: 6278769
    [No Abstract] [Full Text] [Related]

  • 14. Immunotherapy for lung cancer.
    Bradbury PA, Shepherd FA.
    J Thorac Oncol; 2008 Jun; 3(6 Suppl 2):S164-70. PubMed ID: 18520304
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapy.
    Urist MM, Boddie AW, Townsend CM, Holmes EC.
    J Thorac Cardiovasc Surg; 1977 Feb; 73(2):189-94. PubMed ID: 834057
    [Abstract] [Full Text] [Related]

  • 17. Cancer immunotherapy using novel tumor-associated antigenic peptides identified by genome-wide cDNA microarray analyses.
    Nishimura Y, Tomita Y, Yuno A, Yoshitake Y, Shinohara M.
    Cancer Sci; 2015 May; 106(5):505-11. PubMed ID: 25726868
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.